Boehringer Ingelheim has shown biosimilar manufacturers the way to win interchangeability with the world’s highest-grossing drug — but the company’s Cyltezo won't come out until July 2023. Will future Humira competitors have better luck winning an earlier launch date?
Atopic dermatitis patients now have a new therapeutic option that comes as a topical cream. The FDA approved Incyte’s drug, Opzelura, as a treatment for the inflammatory skin condition, but the regulatory nod comes with a black box warning on the label that broadly covers the entire class of JAK inhibitors.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Conservative broadcaster Glenn Beck opened up on his network TheBlazeTV on Monday, and it turns out he has some sort of mysterious illness that he’s been hiding for years from the public. He said he has suffered from vocal chord paralysis, eyesight issues, extreme pain and seizures, but now he’s cured. The rare illness hasn’t […]